Skip to main content

ChEMBL User Group Meeting - Some Details

The agenda for the first ChEMBL user group meeting is below, we also have some additional speakers on various collaborative projects likely to be of interest to attendees, as extra-meeting items. Many thanks to the speakers and to Brad Sherbourne of Merck for putting this together.

The presentations will be a mix of slides and generous discussion time, giving plenty of opportunity to shape the future development of ChEMBL.

Friday May 27th, Courtyard Meeting Room, EMBL-EBI, Hinxton, CB10 1SD.

9.15 Coffee/Reception
9.30 Welcome to ChUG - JPO and Brad
9.45 ChEMBL update and plans - ChEMBL group
10.45 Coffee
11.00 BeautifulBind: Prioritising targets by chemistry - Andrew Hopkins
11.45 Predicting targets using ChEMBL, and application to phospholipidosis - Rob Lowe
12.15 Lunch
13.15 QSAR workbench/Active learning - David Nicolaides
13.45 Matched-pair analysis, ChEMBL and KNIME - George Papadatos
14.15 Anti-Drugs - Willem Van Hoorn
14.45 Coffee
15.00 Comparison of compound to target mapping in ChEMBL and other databases - Chris Southan
15.30 Implementation/interface - Rich Hall
16.00 CanSAR - Mark Halling-Brown
16.30 Close of ChUG meeting
Extra Session
16.35 Stefan Senger - IMI OpenPHACTs Project
16.45 Mike Barnes - RSC Precompetitive activities

There is still time to register, details on the LinkedIn ChEMBL User Group. Travel details are on the EBI website www.ebi.ac.uk, when you arrive, present yourself to Security at the Campus Visitor Center, then you will be sent to the EBI reception where you'll be met and taken to the meeting room.

Comments

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the